Therefore, we assumed that in IgG4-RD patients, the CD19 + CD24-CD38hi B cells may differentiate into IgG4 producing plasma cells or recruit to the involved tissues. The gene discussed is CD19; the disease is immunoglobulin G4-related sclerosing disease.